🔓
Sign in as a Member to unlock the full view of HR.7505. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$29.99/mo already a Member? Sign in →
HR.7505 · 117TH CONGRESS

To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.

Status
Dead
Official Source
Investability
69/100
Stage
COMMITTEE
Related Bills
0
Full Text
3,013 chars
Alive
No

What This Bill Does · Plain English

GovGreed Synthesis · AI extraction
This bill creates a new tax credit for medical research. It adds a fourth component to the existing Research and Development (R&D) tax credit under Section 41 of the Internal Revenue Code. Specifically, it allows companies to claim a credit equal to 14% of their 'specified medical research expenditures,' which are defined as amounts paid for qualified research related to any 'qualified countermeasure.' A qualified countermeasure is a drug, biological product, or device used to treat or prevent harm from a biological, chemical, radiological, or nuclear agent. The credit applies to expenses incurred after the bill becomes law.

Frequently Asked Questions

Did HR.7505 pass?
HR.7505 did not pass and is no longer active. Final stage: COMMITTEE.
What does HR.7505 do?
This bill creates a new tax credit for medical research. It adds a fourth component to the existing Research and Development (R&D) tax credit under Section 41 of the Internal Revenue Code. Specifically, it allows companies to claim a credit equal to 14% of their 'specified medical research expenditures,' which are defined as amounts paid for qualified research related to any 'qualified countermeasure.' A qualified countermeasure is a drug, biological product, or device used to treat or prevent harm from a biological, chemical, radiological, or nuclear agent. The credit applies to expenses incu…

Full Bill Text

117 HR 7505 IH: To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities. U.S. House of Representatives 2022-04-14 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 117th CONGRESS 2d Session H. R. 7505 IN THE HOUSE OF REPRESENTATIVES April 14, 2022 Mr. Buchanan (for himself and Mr. Kelly of Pennsylvania ) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities. 1. New medical research expenditure component of credit for increasing research activities (a) In general Section 41(a) of the Internal Revenue Code of 1986 is amended by striking and at the end of paragraph (2), by striking the period at the end of paragraph (3) and inserting , and , and by adding at the end the following new paragraph: (4) 14 percent of specified medical research expenditures. . (b) Specified medical research expenditures Section 41(f) of such Code is amended by adding at the end the following new paragraph: (7) Specified medical research expenditures (A) In general The term specified medical research expenditures means amounts paid or incurred for qualified research with respect to any qualified countermeasure. (B) Qualified countermeasure The term qualified countermeasure has the meaning given to such term in section 319F–1(a)(2) of the Public Health Service Act (42 U.S.C. 247d–6a(a)(2)). . (c) Denial of double benefit (1) Taxable years beginning before January 1, 2022 In the case of specified medical research expenditures (as defined in section 41(f)(7) of such Code (as added by this section)) paid or incurred in taxable years beginning before January 1, 2022— (A) such expenditures shall be treated in the same manner as qualified research expenses and basic research expenses under section 280C(c)(1) of such Code (as in effect on the day before the enactment of the Tax Cuts and Jobs Act), and (B) the amount determined under section 280C(c)(2)(A) (as in effect on such day) for the taxable year shall be increased by the amount of credit determined for the taxable year under section 41(a)(4) (as added by this section). (2) Taxable years beginning after December 31, 2021 Section 280C(c)(1) of such Code is amended by striking section 41(a)(1) and inserting paragraphs (1) and (4) of section 41(a) . (d) Conforming amendment Section 41(f)(1) of such Code is amended by striking and amounts paid or incurred to energy research consortiums each place it appears and inserting , amounts paid or incurred to energy research consortiums, and specified medical research expenditures . (e) Effective date The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.
🔒 GovGreed Pro · Trading Intelligence on HR.7505 Get Access — $29.99/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-11-17. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]